• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Coliseum Nominates Slate of Highly Qualified and Engaged Director Candidates for Election at Purple Innovation 2023 Annual Meeting

    2/13/23 8:30:00 AM ET
    $BIOS
    $LAZY
    $LOGI
    $MODV
    Blank Checks
    Finance
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary
    Get the next $BIOS alert in real time by email

    Will Support Re-Election of CEO Rob DeMartini to Board

    No Longer Pursuing September 2022 Take Private Proposal

    Shareholders Deserve Nimbler, More Engaged Board with Heightened Sense of Urgency and Bias for Action to Help Management Navigate Challenges Ahead

    Coliseum Capital Partners, L.P. ("Coliseum"), the largest stockholder of Purple Innovation, Inc. (NASDAQ:PRPL) ("Purple"), announced today that it has nominated five candidates for election to Purple's seven member Board of Directors at the company's 2023 Annual Meeting of Stockholders, including Adam Gray, a current Purple director and Managing Partner and Co-Founder of Coliseum Capital Management, LLC.

    Coliseum also announced that it intends to support the re-election of Purple's Chief Executive Officer, Rob DeMartini, and not oppose the election of one other nominee proposed by Purple management after review of their slate. If Mr. DeMartini is not re-elected, Coliseum intends to recommend that he be immediately appointed a director.

    Coliseum also confirmed that it is no longer pursuing its September 2022 proposal to acquire the remaining shares not owned by Coliseum. Coliseum committed that if it does make a similar proposal in the future, it will be conditioned on the same terms as the September 2022 proposal: it must be approved by a special committee of Purple's board and by the holders of a majority of the stock not then owned by Coliseum.

    Coliseum issued the following letter to Purple stockholders which includes background information on Coliseum's nominees:

    Dear fellow stockholders of Purple Innovation, Inc. ("Purple" or the "Company"),

    Five Years After its De-SPAC Merger, Purple's Common Stock Now Trades 54% Below its IPO Price, and 89% Below its All-Time High1

    While we (Coliseum Capital Partners, L.P., together with our affiliates, "Coliseum") are enthusiastic about the Company's longer-term prospects, and strongly supportive of its existing management team, we also recognize that the road ahead – particularly over the next 12-24 months – will be neither straight nor smooth. Purple needs, and shareholders deserve, a far nimbler board with a heightened sense of urgency to help management navigate these challenges and halt further deterioration of shareholder value. As the Company's largest shareholder, our interests are squarely aligned with yours.

    To be clear, we believe that the current non-executive directors are good people with good intentions. Nevertheless, we believe that after five years of disappointing returns it is time for shareholders to demand change. Absent significant change, we no longer have confidence in this board's ability to help steward the Company through current headwinds, and to unlock the value creation that we believe is achievable. Accordingly, and in the absence of agreement with the Company for an overhaul in the non-executive composition of its board, we have decided to pursue this public nomination process. Further, given our conviction that such an overhaul is necessary, we are funding this initiative on behalf of all shareholders without a customary request that the Company reimburse such costs if our slate is elected.

    As you will see below, our proposed directors are accomplished, dynamic business leaders: value creators with deep and relevant experience navigating headwinds, transformation, and growth. We believe, and hope you will agree, that their skillset, fresh perspective, and energized engagement will prove critical for the benefit of all shareholders.

    Our Interests are Squarely Aligned

    We have been strong and consistent supporters of the Company since its February 2018 de-SPAC merger, funding nearly $110 million (about half) of the equity capital Purple has raised to enable the Company's journey to date. With ownership today of nearly 47 million shares of Purple's common stock (approximately 45% of the outstanding common stock), Coliseum is the Company's largest stockholder; our interests are deeply, squarely aligned with yours.

    In contrast, based on our review of public filings, the other five non-executive directors, taken as a whole, have written checks to acquire only approximately 57,000 shares and today hold approximately 323,000 shares (approximately 0.3% of the outstanding common stock).2

    No Longer Pursuing Going-Private; Restating Commitment to Stockholder-Friendly Conditions

    As you may know, in September 2022, Coliseum proposed to take Purple private in a transaction that offered Purple stockholders a 56% premium over Purple's closing stock price the day before our proposal. About four months later, a special committee of Purple's independent directors formally rejected our proposal. While we were disappointed by what we viewed as the special committee's lack of engagement, we respect the special committee's decision. We confirm today that we are no longer pursuing a going-private transaction with Purple.

    Importantly, when we made our proposal in 2022, we insisted that any transaction would occur only if it was supported by an independent, special committee of Purple's board and by holders of a majority of the stock not held by Coliseum. We further confirm today that, while we have no current plan to pursue a going-private transaction with Purple, if we proposed any such transaction in the future, we would commit to those same stockholder-friendly conditions.

    The Road Ahead Will Continue to be Difficult… Requiring a Nimbler, More Engaged Board with Heightened Sense of Urgency and Bias for Action

    Our view -- that Purple has a terrific opportunity to create and unlock substantial value for its shareholders -- has been bolstered by the strength of Rob DeMartini, by the team he is building, and by the clarity with which Rob has outlined and actioned key strategic and operating priorities. That said, Purple faces a tough macroeconomic environment, strong industry headwinds, and aggressive competitive activity. We believe the action we are taking today to refresh the board will lead to a nimbler, more engaged board of directors, critical to support management and to protect shareholders from the elevated downside risk evident at this time.

    Proposed Slate of Director Nominees Highly Qualified to Deliver the Change Shareholders Deserve

    In addition to supporting the reelection of current director and Coliseum co-founder Adam Gray, we are nominating for election to Purple's board four new directors, all of whom are known by us largely through their service as executives and/or board members at other companies in which Coliseum is or was invested where they helped navigate headwinds, transformation and growth, ultimately protecting and driving substantial value for shareholders.

    We hope you will agree that these five director nominees, each of whom is accomplished in her/his own right and shares our commitment to work tirelessly on behalf of all Purple shareholders, represent the change we deserve.

    To be clear, Coliseum is not proposing to change the entire board of Purple because we believe Purple and its stockholders will benefit from the continued service on the board of Purple's Chief Executive Officer, Rob DeMartini, and of Mr. Gray. In fact, if Mr. DeMartini is not reelected to the Purple board, Coliseum intends to recommend that he be immediately appointed to that role.

    Nevertheless, we believe that after five years of disappointing shareholder returns – with the Company's common stock trading 54% below its IPO price and at levels 89% below its all-time high touched February 20213 – the board requires major refreshment. Indeed, three of the existing directors are holdovers who were chosen almost eight years ago to be directors of a blank-check SPAC entity that had no operations. New skillsets and experience are required to oversee Purple's public company operations.

    Below is a brief biography of each of our nominees:

    S. Hoby Darling. Hoby has held several executive roles at Logitech International (NASDAQ:LOGI), including most recently as head of its sports and human performance advisory business. He was previously CEO of Skull Candy (NASDAQ:SKUL), a leading consumer audio and technology company. Prior to joining Skull Candy, Hoby held several roles at Nike, Inc. (NYSE:NKE), including as Global GM of Nike+ Digital Sport and as Head of Strategy and Planning for Nike Affiliates. Prior to Nike, Hoby served as SVP, Strategic Development and General Counsel, at Volcom, Inc. (NASDAQ:VLCM), a leading manufacturer and marketer of consumer lifestyle products. Hoby began his career as a corporate attorney at the global law firm of Latham & Watkins. While we have not worked directly with Hoby, we believe that his multi-channel consumer brand leadership credentials, particularly involving innovative technology and its ability to improve lifestyle outcomes, and his sense of urgency and drive for performance/accountability will be valuable additions to Purple's boardroom.

    Erika Serow. Erika is the Chief Marketing Officer of Bain & Company ("Bain"), responsible for Bain's global marketing and communication teams, and a member of Bain's Global Operating Council (Executive Leadership Team), where she serves on the Investment and Risk committees. Prior to this role, Erika was the Global President and US CEO for Sweaty Betty, a premium athletic apparel company. Erika began her career with a 20-year stint as a consultant at Bain, where she ultimately led the firm's Retail practice in the Americas. We have seen, firsthand, the value Erika has brought to Lazydays Holdings (NASDAQ:LAZY) through her role on its Board of Directors since March of 2018, including on the Nominating and Governance Committee and Compensation Committee. We believe that Erika's deep knowledge and experience helping marquee consumer brands navigate strategy and execution across various stages of transformation, including through each of digital, wholesale, and retail channels, will be of significant value to the Board.

    R. Carter Pate. We have seen Carter add (and protect) enormous value in a number of roles, including as Chairman of BioScrip (NASDAQ:BIOS) and as a board member of its successor company, OptionCare Health (NASDAQ:OPCH), Chairman of Red Lion Hotels (NASDAQ:RLH), and other public company board roles. We also appreciate his tireless work and substantive contributions during his service as the former CEO of ModivCare, Inc (NASDAQ:MODV). Carter's drive and determination, and his experience as part of the Global Leadership Team and in leading the restructuring/performance-improvement practice at PricewaterhouseCoopers, will be terrific complements to this refreshed Purple's board.

    Robert DeVincenzi. We have had the pleasure of working with Bob over many years. Bob currently serves as Chairman of the Board of Universal Technical Institute (NYSE:UTI), and as the Lead Independent Director of Lazydays Holdings Inc. (NASDAQ:LAZY), where he also served as Interim CEO. Prior, Bob served as President and CEO and then as a board member of Redflex Holding Limited; and held a number of other senior executive positions at a variety of technology and services companies, spanning sales, marketing, strategy and more. We believe that Bob's long history of navigating change and creating shareholder value with an operator's keen sense of urgency, bias for action and drive for accountability; his deep knowledge of technology, manufacturing, and supply chain; and his extensive public company board experience will be invaluable within the Purple boardroom.

    Adam Gray. Adam Gray is a managing partner and co-founder of Coliseum, a private firm that makes long-term investments. In this role, he has served on the boards of directors of a number of public and private companies. Prior to launching Coliseum in 2005, Adam worked for nearly 20 years with and on behalf of top-tier private equity firms. We believe that Adam's demonstrated track record of value creation through operating, turnaround and restructuring roles, combined with his private and public equity investing credentials, will help enable Purple's future success.

    * * *

    We are optimistic that, with the significant changes in Purple's governance we are proposing, Purple will be much better positioned to continue its journey as a publicly traded company. As Purple's largest stockholder, with approximately 45% of the outstanding common stock, Coliseum is squarely aligned with you in seeking long-term success for Purple. We believe that success is attainable, but it is not assured; without substantial change, we lack confidence in the current board's ability to help navigate these challenging times.

    We are asking stockholders to think carefully about their options at the upcoming meeting.

    Vote with the Company's largest stockholder and for a reinvigorated slate that is committed to steering the Company towards long-term success.

    Or vote to retain the status quo, despite our lack of confidence in the current board, and risk further destruction of shareholder value.

    We look forward to introducing our slate of nominees to you, and to our continued engagement.

    CERTAIN INFORMATION CONCERNING THE PARTICIPANTS

    Coliseum Capital Partners, L.P. ("CCP"), together with the other participants named herein (collectively, "Coliseum"), intends to file a proxy statement and accompanying universal proxy card with the Securities and Exchange Commission ("SEC") to be used to solicit votes for the election of its slate of nominees for election to the Board of Directors (the "Board") of Purple Innovation, Inc. (the "Company") at the 2023 Annual Meeting of Stockholders of the Company to be held as may be determined by the Board (including any other meeting of stockholders held in lieu thereof, and any adjournments, postponements, reschedulings or continuations thereof, the "Annual Meeting").

    COLISEUM STRONGLY ADVISES ALL STOCKHOLDERS OF THE COMPANY TO READ THE PROXY STATEMENT AND OTHER PROXY MATERIALS, INCLUDING THE PROXY CARD, AS THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. SUCH PROXY MATERIALS WILL BE AVAILABLE AT NO CHARGE ON THE SEC'S WEBSITE AT HTTP://WWW.SEC.GOV. IN ADDITION, THE PARTICIPANTS IN THIS PROXY SOLICITATION WILL PROVIDE COPIES OF THE PROXY STATEMENT WITHOUT CHARGE, WHEN AVAILABLE, UPON REQUEST. REQUESTS FOR COPIES SHOULD BE DIRECTED TO THE PARTICIPANTS' PROXY SOLICITOR, INNISFREE M&A INCORPORATED, AT ITS TOLL-FREE NUMBER 1 888 750 5834 OR VIA EMAIL AT [email protected].

    The participants in the proxy solicitation are anticipated to be Coliseum Capital Partners, L.P., Coliseum Capital, LLC ("Coliseum Capital"), Coliseum Capital Management, LLC ("CCM"), Seth "Hoby" Darling, Robert DeVincenzi, Adam Gray, R. Carter Pate, Erika Serow, Christopher Shackelton, Christopher Murphy and Chivonne Cassar.

    Information regarding the persons who may, under the rules of the SEC, be deemed participants in the solicitation of proxies in connection with the election of Coliseum's nominees as directors of the Company, including a description of their direct or indirect interests, by security holdings or otherwise, will be set forth in the proxy statement and other proxy materials when they are filed with the SEC.

    As of the date hereof, CCP beneficially owns 30,341,629 shares of Class A common stock, par value of $0.0001 per share, of the Company (the "Class A Stock"). As of the date hereof, Coliseum Capital beneficially owns 33,475,078 shares of Class A Stock. As of the date hereof, CCM beneficially owns 40,854,130 shares of Class A Stock. As of the date hereof, Adam Gray beneficially owns 40,854,130 shares of Class A Stock. As of the date hereof, none of Seth "Hoby" Darling, Robert DeVincenzi, R. Carter Pate, Erika Serow, Christopher Murphy or Chivonne Cassar beneficially owns any securities of the Company. As of the date hereof, Christopher Shackelton beneficially owns 40,854,130 shares of Class A Stock.

    ____________________________

    1 Purple common stock closed at $4.56 on February 10, 2023 and $40.05 per share on February 19, 2021. Purple's IPO price in February 2019 was $10 per share.

    2 Excludes shares granted as compensation for Board service or received as a result of cashless exercise of warrants.

    3 Purple common stock closed at $4.56 on February 10, 2023 and $40.05 per share on February 19, 2021. Purple's IPO price in February 2019 was $10 per share

    View source version on businesswire.com: https://www.businesswire.com/news/home/20230213005197/en/

    Get the next $BIOS alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BIOS
    $LAZY
    $LOGI
    $MODV

    CompanyDatePrice TargetRatingAnalyst
    Option Care Health Inc.
    $OPCH
    10/2/2025$30.00Hold
    TD Cowen
    Nike Inc.
    $NKE
    10/2/2025$90.00Sector Weight → Overweight
    KeyBanc Capital Markets
    Nike Inc.
    $NKE
    9/23/2025$70.00 → $75.00Market Perform
    Telsey Advisory Group
    Nike Inc.
    $NKE
    9/18/2025$90.00Sector Perform → Outperform
    RBC Capital Mkts
    Nike Inc.
    $NKE
    9/10/2025$85.00Hold → Buy
    TD Cowen
    Logitech International S.A.
    $LOGI
    8/5/2025$109.00Neutral → Outperform
    BNP Paribas Exane
    Nike Inc.
    $NKE
    7/28/2025$93.00Neutral → Overweight
    Analyst
    Nike Inc.
    $NKE
    7/10/2025$76.00Buy → Hold
    DZ Bank
    More analyst ratings

    $BIOS
    $LAZY
    $LOGI
    $MODV
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Wright Norman L. bought $99,976 worth of shares (3,411 units at $29.31), increasing direct ownership by 28% to 15,501 units (SEC Form 4)

    4 - Option Care Health, Inc. (0001014739) (Issuer)

    9/10/25 4:18:22 PM ET
    $OPCH
    Medical/Nursing Services
    Health Care

    Director Pate R Carter bought $20,391 worth of shares (750 units at $27.19), increasing direct ownership by 2% to 41,910 units (SEC Form 4)

    4 - Option Care Health, Inc. (0001014739) (Issuer)

    8/21/25 6:26:07 PM ET
    $OPCH
    Medical/Nursing Services
    Health Care

    Director Kraemer Harry M Jansen Jr bought $977,278 worth of shares (36,000 units at $27.15), increasing direct ownership by 11% to 375,390 units (SEC Form 4)

    4 - Option Care Health, Inc. (0001014739) (Issuer)

    8/21/25 6:25:33 PM ET
    $OPCH
    Medical/Nursing Services
    Health Care

    $BIOS
    $LAZY
    $LOGI
    $MODV
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Logitech Announces Date for Release of Second Quarter Results for Fiscal Year 2026

    Logitech International (SIX: LOGN) (NASDAQ:LOGI) today announced that it expects to release second quarter fiscal year 2026 financial results on Tuesday, October 28, 2025 at 1:00 p.m. Pacific Daylight Time (PDT) and 09:00 p.m. Central European Time (CET). There will be a videoconference to discuss these results at 1:30 p.m. PDT and 09:30 p.m. CET on the same day. A livestream of the event will be available on the Logitech corporate website at http://ir.logitech.com. About Logitech Logitech designs software-enabled hardware solutions that help businesses thrive and bring people together when working, creating and gaming. As the point of connection between people and the digital world

    10/1/25 4:05:00 PM ET
    $LOGI
    Computer peripheral equipment
    Technology

    Concorde Career Colleges Celebrates National Dental Hygiene Month by Offering No-Cost Dental Services to Local Communities

    Dental cleanings, screenings, and education for kids ages 4 to 17 to spotlight the importance of oral care access KANSAS CITY, Mo., Oct. 1, 2025 /PRNewswire/ -- October is National Dental Hygiene Month, and Concorde Career Colleges is celebrating by hosting no-cost community events at select campuses. The initiative not only honors the dental hygiene profession but also underscores the importance of preventive care and expanding access to oral health services for children and families. According to the CDC, approximately 57 million Americans live in areas with too few dental p

    10/1/25 9:15:00 AM ET
    $UTI
    Other Consumer Services
    Real Estate

    NIKE, Inc. Reports Fiscal 2026 First Quarter Results

    NIKE, Inc. (NYSE:NKE) today reported fiscal 2026 financial results for its first quarter ended August 31, 2025. First quarter revenues were $11.7 billion, up 1 percent on a reported basis compared to the prior year and down 1 percent on a currency-neutral basis* NIKE Direct revenues were $4.5 billion, down 4 percent on a reported basis and down 5 percent on a currency-neutral basis Wholesale revenues were $6.8 billion, up 7 percent on a reported basis and up 5 percent on a currency-neutral basis Gross margin decreased 320 basis points to 42.2 percent Diluted earnings per share was $0.49 "This quarter NIKE drove progress through our Win Now actions in our priority areas of

    9/30/25 4:15:00 PM ET
    $NKE
    Shoe Manufacturing
    Consumer Discretionary

    $BIOS
    $LAZY
    $LOGI
    $MODV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    TD Cowen initiated coverage on Option Care Health with a new price target

    TD Cowen initiated coverage of Option Care Health with a rating of Hold and set a new price target of $30.00

    10/2/25 8:41:19 AM ET
    $OPCH
    Medical/Nursing Services
    Health Care

    NIKE upgraded by KeyBanc Capital Markets with a new price target

    KeyBanc Capital Markets upgraded NIKE from Sector Weight to Overweight and set a new price target of $90.00

    10/2/25 8:35:56 AM ET
    $NKE
    Shoe Manufacturing
    Consumer Discretionary

    Telsey Advisory Group reiterated coverage on NIKE with a new price target

    Telsey Advisory Group reiterated coverage of NIKE with a rating of Market Perform and set a new price target of $75.00 from $70.00 previously

    9/23/25 7:45:13 AM ET
    $NKE
    Shoe Manufacturing
    Consumer Discretionary

    $BIOS
    $LAZY
    $LOGI
    $MODV
    SEC Filings

    View All

    Logitech International S.A. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

    8-K - LOGITECH INTERNATIONAL S.A. (0001032975) (Filer)

    10/2/25 4:08:44 PM ET
    $LOGI
    Computer peripheral equipment
    Technology

    SEC Form 10-Q filed by Nike Inc.

    10-Q - NIKE, Inc. (0000320187) (Filer)

    10/1/25 4:50:25 PM ET
    $NKE
    Shoe Manufacturing
    Consumer Discretionary

    Nike Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - NIKE, Inc. (0000320187) (Filer)

    9/30/25 4:15:31 PM ET
    $NKE
    Shoe Manufacturing
    Consumer Discretionary

    $BIOS
    $LAZY
    $LOGI
    $MODV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP: Chief Legal Officer Leinwand Robert sold $52,367 worth of Class B Common Stock (697 units at $75.13), decreasing direct ownership by 2% to 44,158 units (SEC Form 4)

    4 - NIKE, Inc. (0000320187) (Issuer)

    10/3/25 5:40:44 PM ET
    $NKE
    Shoe Manufacturing
    Consumer Discretionary

    Chief Financial Officer Sethna Meenal was granted 55,067 shares (SEC Form 4)

    4 - Option Care Health, Inc. (0001014739) (Issuer)

    10/3/25 4:15:09 PM ET
    $OPCH
    Medical/Nursing Services
    Health Care

    SEC Form 3 filed by new insider Sethna Meenal

    3 - Option Care Health, Inc. (0001014739) (Issuer)

    10/3/25 4:13:19 PM ET
    $OPCH
    Medical/Nursing Services
    Health Care

    $BIOS
    $LAZY
    $LOGI
    $MODV
    Leadership Updates

    Live Leadership Updates

    View All

    Concorde Career Colleges expands access to respiratory therapy education programs to address rising national demand

    Projected job growth for respiratory therapists is triple the national average for all occupations, federal data shows  KANSAS CITY, Mo., Sept. 17, 2025 /PRNewswire/ -- Concorde Career Colleges, the healthcare education division of Universal Technical Institute, Inc., is expanding access to its respiratory therapy education programs to address the rising demand nationally for skilled therapists. Specifically, Concorde is increasing enrollment in its respiratory therapy programs at nine of its campuses, in addition to growing a hospital partnership model to support rural and remote areas.

    9/17/25 9:15:00 AM ET
    $UTI
    Other Consumer Services
    Real Estate

    Vuori Appoints Andrew Campion to Board of Directors

    The addition of the industry leader reinforces the brand's continued momentum and further fuels its strategic growth priorities Vuori, the performance and lifestyle brand known for its coastal California-inspired style, today announced the appointment of Andrew Campion to its Board of Directors and a member of its Audit Committee. For over 17 years, Andy served in executive leadership roles at Nike Inc. (NYSE:NKE), including as Chief Operating Officer, Chief Financial Officer, and head of global strategy. Prior to Nike, Campion was with The Walt Disney Company (NYSE:DIS), serving as its Senior Vice President of Corporate Development. Currently, Andy is the Chairman and CEO of Unrivaled

    9/15/25 6:00:00 AM ET
    $DIS
    $NKE
    $SBUX
    Services-Misc. Amusement & Recreation
    Consumer Discretionary
    Shoe Manufacturing
    Restaurants

    Option Care Health Announces Chief Financial Officer Transition

    BANNOCKBURN, Ill., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the "Company" or "Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, announced the appointment of Meenal Sethna as Executive Vice President and Chief Financial Officer, effective October 1, 2025. Sethna will succeed Mike Shapiro, who has decided to step down as CFO effective September 30, 2025, following a decade of service to the Company. At the time of the transition, Shapiro will remain with the Company as a Strategic Advisor through at least the first quarter of 2026 to continue to help advance the Company's strategy and ensure a smooth

    8/20/25 8:45:00 AM ET
    $LFUS
    $OPCH
    Electrical Products
    Energy
    Medical/Nursing Services
    Health Care

    $BIOS
    $LAZY
    $LOGI
    $MODV
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by ModivCare Inc.

    SC 13D/A - ModivCare Inc (0001220754) (Subject)

    12/13/24 9:05:42 PM ET
    $MODV
    Transportation Services
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by ModivCare Inc.

    SC 13D/A - ModivCare Inc (0001220754) (Subject)

    12/13/24 5:07:48 PM ET
    $MODV
    Transportation Services
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by ModivCare Inc.

    SC 13D/A - ModivCare Inc (0001220754) (Subject)

    12/9/24 7:46:13 PM ET
    $MODV
    Transportation Services
    Consumer Discretionary

    $BIOS
    $LAZY
    $LOGI
    $MODV
    Financials

    Live finance-specific insights

    View All

    Logitech Announces Date for Release of Second Quarter Results for Fiscal Year 2026

    Logitech International (SIX: LOGN) (NASDAQ:LOGI) today announced that it expects to release second quarter fiscal year 2026 financial results on Tuesday, October 28, 2025 at 1:00 p.m. Pacific Daylight Time (PDT) and 09:00 p.m. Central European Time (CET). There will be a videoconference to discuss these results at 1:30 p.m. PDT and 09:30 p.m. CET on the same day. A livestream of the event will be available on the Logitech corporate website at http://ir.logitech.com. About Logitech Logitech designs software-enabled hardware solutions that help businesses thrive and bring people together when working, creating and gaming. As the point of connection between people and the digital world

    10/1/25 4:05:00 PM ET
    $LOGI
    Computer peripheral equipment
    Technology

    NIKE, Inc. Reports Fiscal 2026 First Quarter Results

    NIKE, Inc. (NYSE:NKE) today reported fiscal 2026 financial results for its first quarter ended August 31, 2025. First quarter revenues were $11.7 billion, up 1 percent on a reported basis compared to the prior year and down 1 percent on a currency-neutral basis* NIKE Direct revenues were $4.5 billion, down 4 percent on a reported basis and down 5 percent on a currency-neutral basis Wholesale revenues were $6.8 billion, up 7 percent on a reported basis and up 5 percent on a currency-neutral basis Gross margin decreased 320 basis points to 42.2 percent Diluted earnings per share was $0.49 "This quarter NIKE drove progress through our Win Now actions in our priority areas of

    9/30/25 4:15:00 PM ET
    $NKE
    Shoe Manufacturing
    Consumer Discretionary

    Option Care Health to Announce Third Quarter 2025 Financial Results and Host Conference Call

    BANNOCKBURN, Ill., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Option Care Health Inc. ("Option Care Health") (NASDAQ: OPCH), the nation's largest independent provider of home and alternate site infusion services, today announced that the company will release results for its third quarter ended September 30, 2025 on Thursday, October 30, 2025 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day. Conference Call DetailsParticipants can pre-register for the conference call at the following link: https://register-conf.media-server.com/register/BI9e5bd109ef23408dbd76380aed8d4b05. The call can also be accessed v

    9/25/25 4:05:00 PM ET
    $OPCH
    Medical/Nursing Services
    Health Care